-
1 Comment
China Grand Pharmaceutical and Healthcare Holdings Limited is currently in a long term uptrend where the price is trading 2.2% above its 200 day moving average.
From a valuation standpoint, the stock is 97.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
China Grand Pharmaceutical and Healthcare Holdings Limited's total revenue rose by 3.1% to $3B since the same quarter in the previous year.
Its net income has increased by 77.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 294.2% to $219M since the same quarter in the previous year.
Based on the above factors, China Grand Pharmaceutical and Healthcare Holdings Limited gets an overall score of 5/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | BMG210A71016 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 8.49 |
|---|---|
| Market Cap | 21B |
| Target Price | 7.2267 |
| Dividend Yield | 4.3% |
| Beta | 0.79 |
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. The company has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0512.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
